Nektar Therapeutics (ITH.F) Q3 2024 Earnings

Aug 8Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.23
-0.21
-0.19
-0.17

Details

Expected EPS
-0.16946185
Actual EPS
-0.2290025
Surprise EPS
-0.06
Surprise Percent
-35.14%

Description

⁨Nektar Therapeutics⁩ (⁦ITH.F⁩) has reported earnings of ⁦-0.2290025⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts